Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01842087
Other study ID # 16-2010
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2010
Est. completion date November 2010

Study information

Verified date March 2020
Source University of Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A single blind, six week dietary intervention will be conducted in order to evaluate the impact of fiber fortified foods on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function.


Description:

Chronic Kidney Disease (CKD) patients may consume lower than recommended amounts of dietary fiber due to typical dietary habits, dietary restrictions, and uremic symptoms. A progressive decline in kidney function causes an accumulation of uremic molecules that contribute to further progression of the disease and reduced quality of life. In an effort to evaluate the impact of added fiber on blood urea nitrogen, kidney function and quality of life in patients presenting with a moderate to severe decline in kidney function (eGFR ≤ 50 mL/min/1.73 m2), a single blind, six week dietary intervention, clinical trial will be conducted.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date November 2010
Est. primary completion date November 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Participants must:

- Be 18 years of age or older

- Have eGFR (estimated glomerular filtration rate) of less than 50 mL/min/1.73 m2 (stage 3,4 and 5 but who are not on dialysis)

Exclusion Criteria:

Participants must not:

- Have been diagnosed with acute kidney injury (AKI)

- Have been diagnosed with glumerulonephritis (GN)

- Have been on immunosuppressant/steroid medications

- Be taking a probiotic supplement and refuse to discontinue it

- Be scheduled for dialysis within 3 months of study initiation

- Have a history of liver disease

- Be on dialysis

- Have undergone renal transplantation

- Be breastfeeding

- Have active gastrointestinal bleeding

- Have a change in medications over the past 4 weeks

Study Design


Intervention

Other:
Control Food
For a period of 2 weeks, participants will consume control foods in addition to their usual diets.
Fiber Fortified Food
For a period of 4 weeks, participants will consume food fortified with fiber in addition to their usual diets.

Locations

Country Name City State
United States University of Florida Gainesville Florida

Sponsors (2)

Lead Sponsor Collaborator
University of Florida Saskatchewan Pulse Growers

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Impact of added fiber on blood urea nitrogen (BUN) Blood samples (10 mL) will be taken on day 1, 14, 28, and 42. BUN will be assayed using the Urea Nitrogen Concentrated Reagent method. up to 42 days of the study
Secondary Impact of foods with added fiber on estimated Glomerular Filtration Rate (eGFR) eGFR will be calculated using the Modification of Diet in Renal Disease formula on days 1, 14, 28 and 42 of the study. Days 1, 14, 28 and 42 of the study
Secondary Impact of foods with added fiber on Serum Creatinine Serum creatinine will be assayed using the ADVIA Chemistry CRE_2c method. Days 1, 14, 28 and 42 of the study
Secondary Impact of foods with added fiber on bowel movement frequency Participants will complete daily diaries to evaluate bowel movement frequency. Daily
Secondary Impact of foods with added fiber on Kidney Disease Quality of Life (KDQOL-36) questionnaire Participants will complete the Kidney Disease Quality of Life (KDQOL-36) questionnaire for 4 specific days during the study. Days 1, 14, 28 and 42
Secondary Impact of foods with added fiber on Simplified Nutritional Appetite Questionnaire (SNAQ) Days 1, 14, 28 and 42 of the study
Secondary Impact of foods with added fiber on Epworth Sleepiness Scale (ESS) Days 1, 14, 28 and 42 of the study
Secondary Impact of foods with added fiber on Gastrointestinal Symptom Rating Scale (GSRS) Days 1, 14, 28 and 42 of the study
See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4